SEC 13F Intelligence

Amova Asset Management Americas, Inc. / BEAM

Amova Asset Management Americas, Inc.’s Beam Therapeutics Inc Position

Does Amova Asset Management Americas, Inc. own Beam Therapeutics Inc (BEAM)? Yes3.83M shares worth $91M (+1.29% of its 13F portfolio) as of Q1 2026, down from 4.41M shares the prior filed quarter.

Position Value
$91M
Q1 2026
Shares
3.83M
% of Portfolio
+1.29%
Quarters Held
22
currently held

Position History BEAM

Reported value by quarter
Q4 ’20: $17MQ4 ’20Q1 ’21: $18MQ2 ’21: $33MQ3 ’21: $22MQ3 ’21Q4 ’21: $18MQ1 ’22: $16MQ2 ’22: $11MQ2 ’22Q3 ’22: $24MQ4 ’22: $26MQ1 ’23: $20MQ1 ’23Q2 ’23: $39MQ3 ’23: $39MQ4 ’23: $64MQ4 ’23Q1 ’24: $78MQ2 ’24: $52MQ3 ’24: $87MQ3 ’24Q4 ’24: $98MQ1 ’25: $83MQ2 ’25: $80MQ2 ’25Q3 ’25: $117MQ4 ’25: $122MQ1 ’26: $91MQ1 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q1 20263.83M$91M+1.29%
Q4 20254.41M$122M+1.41%
Q3 20254.83M$117M+1.14%
Q2 20254.73M$80M+0.80%
Q1 20254.27M$83M+1.07%
Q4 20243.96M$98M+1.06%
Q3 20243.55M$87M+0.99%
Q2 20242.22M$52M+0.60%
Q1 20242.36M$78M+0.77%
Q4 20232.36M$64M+0.62%
Q3 20231.64M$39M+0.47%
Q2 20231.22M$39M+0.41%
Q1 2023658.6K$20M+0.23%
Q4 2022673.7K$26M+0.38%
Q3 2022510.9K$24M+0.30%
Q2 2022292.0K$11M+0.13%
Q1 2022283.5K$16M+0.12%
Q4 2021225.2K$18M+0.09%
Q3 2021254.4K$22M+0.10%
Q2 2021253.6K$33M+0.13%
Q1 2021229.4K$18M+0.09%
Q4 2020204.2K$17M+0.09%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Amova Asset Management Americas, Inc.’s full portfolio or all institutional holders of BEAM.